# Novavax Inc: Form 8-K, filed May 5, 2025

- Company: [Novavax Inc](/companies/nvax.md) (CIK 1000694)
- Form: 8-K
- Filed: 2025-05-05
- Accepted by EDGAR: May 5, 2025, 09:25 ET
- Period: 2025-05-05
- Accession: 0001104659-25-044372
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1000694/000110465925044372/tm2513960d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1000694/000110465925044372/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1000694/000110465925044372/tm2513960d1_8k.htm

Filed May 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-044372. Last ingested by Listed: Oct 29, 2026, 16:32 ET. No prices; not investment advice.